Copenhagen researchers tested weekly semaglutide with CBT in 108 adults with alcohol use disorder and obesity, and blood tests backed up the drop in drinking.
Recap by typeshit. Full story at health.
A short item claims a newer group of weight loss drugs beats Ozempic, without naming the drugs or the data behind the claim.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
The obesity medicine specialist told a Fall Clinical 2026 panel that sleep apnea, MASH and heart coverage can open GLP-1 access, and that retatrutide could reach market next year.
In a 12-week study of 245 adults, Omada reports its members cut body fat percentage about twice as much as usual care. Results go to WOC 2026 in Boston.
A generic Facebook post aimed at people on Ozempic, Wegovy, Zepbound or Mounjaro, teasing an overlooked side of treatment without saying what it is.
CDC figures say nearly three in four US adults felt very tired some days lately. A local practice promotes peptides and NAD for energy, claims that are its own.
Loading…